Pharmaceutical Executive
Safety Risks, Generic Threat Scale Down Big Hopes
Pharmaceutical Executive-11-07-2007
Pharmaceutical Executive
Bright Spots Are Emerging Markets, Specialty Drugs, Says IMS Health
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5